Sign Up to like & get recommendations! 1
Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5740
Abstract: Hepatitis B core antibody (HBcAb) positivity is considered a prior hepatitis B virus (HBV) infection. However, little is known about the effect of HBcAb positivity on surgical safety for hilar cholangiocarcinoma (hCCA). The present study… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25739
Abstract: Open surgery for hilar cholangiocarcinoma (HCCA) has already been widely reported and analyzed. However, the laparoscopic technique for treating HCCA remains controversial because of the lack of radicality and poor assessment of the resectability of… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Surgical Endoscopy"
DOI: 10.1007/s00464-025-11742-0
Abstract: Robotic surgery (RS) has gained increasing acceptance due to its ability to overcome certain limitations associated with laparoscopic surgery (LS). However, the performance of RS in hilar cholangiocarcinoma (HCCA) patients compared with LS remain unclear.… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical imaging"
DOI: 10.1016/j.clinimag.2019.12.020
Abstract: OBJECTIVES To explore the characteristics of hepatic plexuses and celiac ganglia, and their relationships with hilar cholangiocarcinoma (HCCA) perineural invasion (PNI) by computed tomography (CT) imaging preliminarily. MATERIALS AND METHODS Sixty-five HCCA patients (55 with… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Photodiagnosis and photodynamic therapy"
DOI: 10.1016/j.pdpdt.2022.102712
Abstract: BACKGROUND Photodynamic therapy (PDT) is a novel therapy evaluated for the treatment of cancers resistant to standard oncological treatments. PDT might be beneficial for the palliation of hilar cholangiocarcinoma. AIM To evaluate the efficacy and… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-025-10329-y
Abstract: Hilar cholangiocarcinoma (hCCA), a rare cancer of the biliary system, has a poor prognosis. This study aimed to investigate the risk factors affecting the survival of patients with hCCA after curative-intent resection and establish a… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Endoscopy"
DOI: 10.1055/a-2037-5131
Abstract: An 86-year-old man who had undergone placement of multiple uncovered self-expandable metal stents (U-SEMSs) by the stent-in-stent (SIS) method for hilar cholangiocarcinoma presented with fever. Blood tests revealed elevated levels of inflammatory markers and liver… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000012025
Abstract: Background: The aim of this study was to compare the clinical outcomes between patients with preoperative cholangitis and noncholangitis patients to determine whether the preoperative cholangitis would be able to serve as an independent predictive… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Medicine"
DOI: 10.1097/md.0000000000020237
Abstract: Abstract Objectives: To compare the clinical outcomes of endoscopic biliary drainage (EBD) with those of percutaneous transhepatic biliary drainage (PTBD) in patients with resectable hilar cholangiocarcinoma (HCCA) and evaluate the effect of EBD and PTBD… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000002574
Abstract: Objective: To investigate the influence of type of surgery (transplant vs resection) on overall survival (OS) in patients with hilar cholangiocarcinoma (H-CCA). Background: Outcomes after resection for H-CCA are poor, yet transplantation is currently only… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.15955
Abstract: To outline our experience with the radical resection of hilar cholangiocarcinoma (HCCA) combined with the partial resection of the pancreatic head (RRHCCAPRPH) as a treatment for HCCA with distal bile duct involvement and to appraise… read more here.